Robert Nussenblatt
7Patents
5h-index
16Co-inventors
60Inventor score
Filing activity: Dec 20, 1989 → Jun 2, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6713081B2 | Ocular therapeutic agent delivery devices and methods for making and using such devices | Emerging Cross-Sectional Technologies | 272 | Expired |
| US5294604A | Method of treating ocular diseases by periocular administration of cyclosporine A or G | Emerging Cross-Sectional Technologies | 49 | Expired |
| US5597567A | Blocking cell adhesion molecules and treating animals with ocular inflammation | Human Necessities | 43 | Expired |
| US7658364B2 | Ocular therapeutic agent delivery devices and methods for making and using such devices | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5961977A | Method of treating or preventing autoimmune uveoretinitis in mammals | Human Necessities | 6 | Expired |
| US11173195B2 | Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta | Human Necessities | 0 | Active |
| US10709774B2 | Immunomodulatory pharmaceutical compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.